WADDELL & REED FINANCIAL INC - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 321 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
WADDELL & REED FINANCIAL INC ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$72,563,000
-40.3%
1,613,947
-25.0%
0.15%
-41.8%
Q4 2020$121,605,000
+19.2%
2,150,7700.0%0.26%
+4.5%
Q3 2020$102,054,000
-20.1%
2,150,770
-0.7%
0.24%
-25.8%
Q2 2020$127,727,000
+24.7%
2,166,325
+0.0%
0.33%
-0.9%
Q1 2020$102,423,000
-22.6%
2,166,311
-1.1%
0.33%
+1.5%
Q4 2019$132,306,000
-30.6%
2,190,137
-31.1%
0.33%
-33.5%
Q3 2019$190,518,000
-6.8%
3,180,078
+0.0%
0.49%
-2.6%
Q2 2019$204,382,000
-25.1%
3,180,059
-5.4%
0.51%
-25.1%
Q1 2019$272,918,000
+44.3%
3,362,306
-3.9%
0.68%
+26.1%
Q4 2018$189,105,000
-4.3%
3,498,062
-8.7%
0.54%
+22.4%
Q3 2018$197,691,000
+4.7%
3,832,711
-15.4%
0.44%
+0.5%
Q2 2018$188,769,000
-5.5%
4,530,1000.0%0.44%
-3.8%
Q1 2018$199,687,000
-12.4%
4,530,1000.0%0.45%
-10.5%
Q4 2017$227,865,000
-1.1%
4,530,100
-0.3%
0.51%
-1.2%
Q3 2017$230,285,000
-11.9%
4,542,100
-11.6%
0.51%
-11.0%
Q2 2017$261,482,000
+26.3%
5,140,200
-0.2%
0.58%
+30.7%
Q1 2017$207,055,000
-24.6%
5,150,600
-10.3%
0.44%
-26.9%
Q4 2016$274,678,000
+29.0%
5,742,800
-1.2%
0.60%
+36.5%
Q3 2016$213,003,000
+53.7%
5,813,400
-2.3%
0.44%
+51.0%
Q2 2016$138,557,000
-41.0%
5,949,200
+2.6%
0.29%
-33.8%
Q1 2016$234,944,000
-34.3%
5,801,100
+0.5%
0.44%
-23.8%
Q4 2015$357,355,0005,770,3000.58%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders